Homology Medicines Inc. (FIXX) Fundamentals

Homology Medicines Inc is a US-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.
SHARE INFORMATION
Market Cap$ 116,492,723
Shares Outstanding57,385,578
Float46,831,078
Percent Float81.61%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 33,971,000
Latest Fiscal EPS$ -1.69
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions302
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months1,512,867
Institutional Holdings Percent81.0%
Institutional Sold Previous 3 Months10,834,394
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months-
Insider Holdings Percent0.8
Insider Sold Previous 3 Months-
Insider Shares Owned477,447
TRADING INFO
52 Week High$ 8.90
52 Week Low$ 1.30
52 Week High Change$ -72.23
21 Day Moving Average$ 1.8452
21 Day Extended Moving Average$ 1.9019
50 Day Moving Average$ 1.7742
50 Day Extended Moving Average$ 2.0037
200 Day Moving Average$ 3.988
200 Day Extended Moving Average$ 3.8083
10 Day Average Volume835,105
20 Day Average Volume691,922
30 Day Average Volume598,704
50 Day Average Volume522,502
Alpha-0.032288
Beta-0.2143
Standard Deviation0.172775
R20.003946
7 Day Price Change$ 0.24
7 Day Percent Change13.41%
21 Day Price Change$ 0.27
21 Day Percent Change15.34%
30 Day Price Change$ 0.64
30 Day Percent Change46.04%
Month to Date Price Change$ 0.56
Month to Date Percent Change38.1%
Quarter to Date Price Change$ -1.01
Quarter to Date Percent Change-33.22%
180 Day Price Change$ -2.11
180 Day Percent Change-50.97%
200 Day Price Change$ -2.42
200 Day Percent Change-54.38%
Year to Date Price Change$ -1.61
Year to Date Percent Change-44.23%

Homology Medicines Inc. (FIXX) Key Ratios

PROFITABILITY
EBIT Margin-2,422.4%
EBITDA Margin-2,301.3%
Pre-Tax Profit Margin0.0%
Profit Margin Count9.92%
Gross Margin0.0%
Profit Margin TOT9.92%
INCOME STATEMENTS
Revenue$ 5,468,000
Revenue Per Share$ 0.0953
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.40
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio12.60
Leverage Ratio1.20
Quick Ratio12.30
Long Term Debt To Capital0.08
VALUATION MEASURES
PE Ratio-25.40
Enterprise Value$ -115,650,277
Price to Sales21.3044
Price to Free Cash7.00
PE High Last 5 Years0.00
Price To Book0.40
Price To Cash Flow57.40
PE Low Last 5 Years0.00
Price to Tangible Book0.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-0.97
Return on Equity-1.13
Return on Capital-1.09

Homology Medicines Inc. (FIXX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorDeloitte & Touche LLP
CEOArthur O. Tzianabos
Emplyoees104
Last AuditUQ
CIK0001661998
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressOne Patriots Park
Bedford, MA 1730
Websitehttps://www.homologymedicines.com
Facsimile-
Telephone+1 781 301-7277
Emailinfo@homologymedicines.com


Your Recent History
NASDAQ
FIXX
Homology M..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.